Evidence map›Paper›PMID 38111764›Full record

ArticleWorld journal of gastrointestinal surgery2023

Organ sparing to cure stage IV rectal cancer: A case report and review of literature.

Hélène Meillat, Jonathan Garnier, Anais Palen, Jacques Ewald, Cécile de Chaisemartin, Marguerite Tyran, Emmanuel Mitry, Bernard Lelong

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of gastrointestinal surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. The emerging role of watch and wait in metastatic rectal cancer.International journal of colorectal disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hélène MeillatDepartment of Digestive Surgical Oncology, Institut Paoli Calmettes, Marseille 13009, France. meillath@ipc.unicancer.fr.
Jonathan GarnierDepartment of Digestive Surgical Oncology, Institut Paoli Calmettes, Marseille 13009, France.
Anais PalenDepartment of Digestive Surgical Oncology, Institut Paoli Calmettes, Marseille 13009, France.
Jacques EwaldDepartment of Digestive Surgical Oncology, Institut Paoli Calmettes, Marseille 13009, France.
Cécile de ChaisemartinDepartment of Digestive Surgical Oncology, Institut Paoli Calmettes, Marseille 13009, France.
Marguerite TyranDepartment of Radiotherapy, Institut Paoli Calmettes, Marseille 13009, France.
Emmanuel MitryDepartment of Digestive Surgical Oncology, Institut Paoli Calmettes, Marseille 13009, France.
Bernard LelongDepartment of Digestive Surgical Oncology, Institut Paoli Calmettes, Marseille 13009, France.
Institut Paoli-Calmettes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRectal sparing is an option for some rectal cancers with complete or good response after chemoradiotherapy (CRT); however, it has never been evaluated in patients with metastases. We assessed long-term outcomes of a rectal-sparing approach in a liver-first strategy for patients with rectal cancer with resectable liver metastases. CASE SUMMARY: We examined patients who underwent an organ-sparing approach for rectal cancer with synchronous liver metastases using a liver-first strategy during 2010-2015 (

conclusionThe results suggest good local control in patients undergoing organ-sparing strategies for rectal cancer with synchronous liver metastasis. Prospective trials are required to validate these data and identify good candidates for these strategies.

Indexed as

Colorectal cancerLiver metastasisPver-first strategyRectal sparing

Identifiers

PMID38111764
PMCPMC10725537
OpenAlexW4389010783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.